BRIEF

on INVENTIVA (EPA:IVA)

Inventiva Announces 2024 Full-Year Financial Results Schedule

Stock price chart of INVENTIVA  (EPA:IVA) showing fluctuations.

Inventiva, a clinical-stage biopharmaceutical company, will release its 2024 full-year financial results on March 26, 2025. The results will be published at 4:00 pm New York time, and 9:00 pm Paris time. The following day, March 27, 2025, CEO Frédéric Cren and CFO Jean Volatier will host a webcast to present these results.

The presentation will occur at 8:00 am in New York and 1:00 pm in Paris, featuring a Q&A session. Participants must register in advance to access the conference, using details provided in a confirmation email. A replay will be accessible on Inventiva's website afterward.

Inventiva focuses on developing oral small molecule therapies for treating MASH and other conditions with unmet medical needs. Their developments include lanifibranor, currently in Phase 3 clinical trials for MASH treatment.

R. E.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all INVENTIVA news